T 1676/21 (Combination of AKT inhibitor compound and abiraterone/ GENENTECH) of 22.11.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T167621.20231122
- Date of decision
- 22 November 2023
- Case number
- T 1676/21
- Online on
- 15 January 2024
- Petition for review of
- -
- Application number
- 12764765.9
- IPC class
- A61K 31/517A61P 35/00C07D 239/70
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- COMBINATION OF AKT INHIBITOR COMPOUND AND ABIRATERONE FOR USE IN THERAPEUTIC TREATMENTS
- Applicant name
- Genentech, Inc.
- Opponent name
- Generics (UK) Ltd
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 87(1)European Patent Convention Art 56
- Keywords
- Priority - basis in priority document (no)
Main request - Inventive (Yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.